Quantcast

Latest Indoles Stories

2014-10-16 12:28:14

Launch of Novel Immune Checkpoint Inhibitors Will Fuel Market Growth and Will Dramatically Enhance RCC Treatment Algorithm, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for renal cell carcinoma (RCC) therapies will grow to approximately $2.5 billion by 2023, despite the aggressive generic erosion of Pfizer's Sutent, GlaxoSmithKline's Votrient, Pfizer's Inlyta, Bayer HealthCare/Onyx...

2014-10-15 23:01:37

New research report “Global Cancer Kinase Inhibitors Market & Pipeline Insight” elaborated by Kuick Research is now available at MarketPublishers.com. According to the study, the global kinase inhibitors market is poised to gain momentum through 2018. London, UK (PRWEB) October 15, 2014 The field of cancer is developing driven primarily by the ageing world population, soaring rates of smoking, and the growth in obesity across all geographies. This opens up a slew of nice...

2014-09-19 08:25:32

VIENNA, September 19, 2014 /PRNewswire/ -- Australian researchers have discovered that the reductions in heart events and death, from using blood pressure-lowering drugs in patients with type 2 diabetes, persist for many years after treatment has stopped. The global study has found that, six years after stopping intensive treatment with the combination of perindopril and indapamide, patients with type 2 diabetes continued to have a lower risk of serious heart disease...

2014-08-11 12:26:57

Significant Opportunity Exists for New Therapies to Treat GIST, Particularly those for Treating Unresectable and/or Metastatic Disease in Later-Line Settings BURLINGTON, Mass., Aug. 11, 2014 /PRNewswire/ -- Decision Resources Group finds that the treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through 2023 as no new therapies are expected to launch for this indication. Treatment of GIST is largely dependent on tumor size, location and growth rate and...

2014-04-22 12:31:30

LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/gastrointestinal_stromal_tumor_gist_global_clinical_trials_review.html Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Gastrointestinal Stromal Tumor (GIST) Global...

2014-02-20 04:21:29

WHIPPANY, N.J., Feb. 20, 2014 /PRNewswire/ -- Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga(®) (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases. The randomized, double-blind, placebo-controlled Phase III trial is designed to determine the effects of Stivarga as adjuvant treatment following surgical removal of liver metastases.(1) "Patients with more advanced colorectal cancer often...

2013-12-05 23:23:04

A recent study featured in the latest issue of The Oncologist shows that active smoking greatly diminishes patients’ chances of responding to chemotherapeutic treatment for renal cell carcinoma (RCC). The research team, jointly led by Dr. Michael Carducci from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD and Dr. Daniel Keizman from the Sackler School of Medicine at Tel Aviv University, conducted a retrospective analysis exploring the association of...

2013-11-19 12:17:25

Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia, and colleagues determined the effects of varespladib, a drug that inhibits the enzyme secretory phospholipase A2 on cardiovascular risk in patients with acute coronary syndrome (ACS; such as heart attack or unstable angina). Despite contemporary therapies, patients with ACS face a substantial risk of early, recurrent adverse cardiovascular...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.